Abstract
Metallo-β-lactamase domain-containing protein 2 (MBLAC2) is a major off-target of histone deacetylase (HDAC) inhibitors.
©2022 American Association for Cancer Research
2022
American Association for Cancer Research
You do not currently have access to this content.